The findings demonstrated that aspirin use was significantly associated with a reduced risk of CAD events in patients with elevated Lp(a) (HR: 0.54, 95% CI: 0.32–0.94; p = 0.03) [53]. This evidence concerns the gene LPA and coronary artery disorder.